Zobrazeno 1 - 10
of 40
pro vyhledávání: '"A. V. Foteeva"'
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 12, Iss 2, Pp 198-205 (2023)
Introduction. Providing high-quality, effective and safe drugs intended for the treatment of rare (orphan) diseases among the population of the Member States of the Union is one of the most significant and promising development vectors for manufactur
Externí odkaz:
https://doaj.org/article/d94b3f509a034842b77177f5cd97dd1a
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 11, Iss 4, Pp 133-138 (2022)
Introduction. New requirements for the registration of generic drugs after the entry of the Russian Federation into the Eurasian Economic Union (EAEU) and the signing of the Agreement on Common Principles and Rules for the Circulation of Medicinal Pr
Externí odkaz:
https://doaj.org/article/d8b6d93e09314d44add9d12539fc85d5
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 11, Iss 1, Pp 159-164 (2022)
Introduction. An important task for pharmaceutical manufacturers is to bring high quality, effective and safe medicines to the market. In the event that the country's resources are not enough, drugs that have been successfully registered in other cou
Externí odkaz:
https://doaj.org/article/aad5f9ff7a2246359f4c3d9ef50685bb
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 10, Iss 2, Pp 155-161 (2021)
Introduction. One of the main business objectives of Russian pharmaceutical companies is export development. To obtain marketing authorization in countries with a good potential for business it is of greater importance to be competent in drugs regist
Externí odkaz:
https://doaj.org/article/6ea44726562441d98ea3052e1c783748
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 9, Iss 4, Pp 171-179 (2020)
Introduction. At the stage of transition from national to a uniform of circulation of pharmaceutical products regulation at the Eurasian Economic Union (EAEU) framework, harmonization of requirements for the development of medicines determines the ne
Externí odkaz:
https://doaj.org/article/37c6189826c84d74a878a96e60244b67
Publikováno v:
Pharmaceutical Chemistry Journal. 56:110-117
Vildagliptin is an oral agent which is a member of a new class of hypoglycemic drugs, dipeptidylpeptidase-4 (DPP-4) inhibitors. This review presents the physicochemical properties of vildagliptin and assesses analysis methods for its estimation in su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e27ba1f17c1a69183d6bffdeb6090868
https://doi.org/10.1007/s11094-022-02606-1
https://doi.org/10.1007/s11094-022-02606-1
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 9, Iss 4, Pp 171-179 (2020)
Introduction. At the stage of transition from national to a uniform of circulation of pharmaceutical products regulation at the Eurasian Economic Union (EAEU) framework, harmonization of requirements for the development of medicines determines the ne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74c0e84d62aee930ed601519faebdcb2
https://doi.org/10.33380/2305-2066-2020-9-4-171-179
https://doi.org/10.33380/2305-2066-2020-9-4-171-179
Publikováno v:
Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny. 29(6)
The medication support of patients with rare (orphan) diseases is an actual issue, since it requires significant financial costs due to high price of medications. The accessibility of these medications to such patients should be regulated by state in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::683a51ada1dcdc9924380de250c0b6e7
https://pubmed.ncbi.nlm.nih.gov/34882322
https://pubmed.ncbi.nlm.nih.gov/34882322
Publikováno v:
Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny. 29(4)
The article considers such new approaches to information maintenance of medicinal preparation in package as requirements for presentation of information, its location according its importance, availability of warning information. The article focuses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14b44ed810fc97df9a9136f07b0c3ed8
https://pubmed.ncbi.nlm.nih.gov/34486867
https://pubmed.ncbi.nlm.nih.gov/34486867
Autor:
Polyakova, E. B.1 (AUTHOR), Sabirzyanov, D. R.1,2 (AUTHOR) d.sabirzyanov@medisorb.ru, Prozorova, N. A.1 (AUTHOR), Foteeva, A. V.1 (AUTHOR)
Publikováno v:
Pharmaceutical Chemistry Journal. Apr2022, Vol. 56 Issue 1, p110-117. 8p.